Citigroup’s Endocyte, Inc. Common Stock ECYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-1,190
Closed -$21K 7970
2018
Q3
$21K Buy
+1,190
New +$20.4K ﹤0.01% 7077
2018
Q2
Sell
-288
Closed -$3K 7861
2018
Q1
$3K Sell
288
-1,225
-81% -$6.76K ﹤0.01% 7332
2017
Q4
$6K Buy
+1,513
New +$7.21K ﹤0.01% 7210
2017
Q2
Sell
-304
Closed -$1K 7612
2017
Q1
$1K Sell
304
-37,941
-99% -$87.8K ﹤0.01% 7146
2016
Q4
$98K Buy
38,245
+27,653
+261% +$79.4K ﹤0.01% 5788
2016
Q3
$33K Buy
10,592
+1,079
+11% +$3.36K ﹤0.01% 5931
2016
Q2
$30K Sell
9,513
-27,312
-74% -$100K ﹤0.01% 5906
2016
Q1
$114K Buy
36,825
+17,843
+94% +$58.3K ﹤0.01% 5576
2015
Q4
$76K Buy
18,982
+17,545
+1,221% +$80.8K ﹤0.01% 5602
2015
Q3
$7K Sell
1,437
-16,983
-92% -$88.9K ﹤0.01% 6620
2015
Q2
$96K Buy
18,420
+8,984
+95% +$53.9K ﹤0.01% 5037
2015
Q1
$59K Sell
9,436
-6,908
-42% -$39.9K ﹤0.01% 5454
2014
Q4
$103K Buy
16,344
+12,168
+291% +$74.2K ﹤0.01% 5208
2014
Q3
$25K Buy
4,176
+3,863
+1,234% +$26.4K ﹤0.01% 5767
2014
Q2
$2K Sell
313
-27,594
-99% -$311K ﹤0.01% 6821
2014
Q1
$665K Buy
27,907
+467
+2% +$6.77K ﹤0.01% 3225
2013
Q4
$293K Buy
27,440
+6,370
+30% +$70.3K ﹤0.01% 4300
2013
Q3
$281K Buy
21,070
+2,684
+15% +$42.4K ﹤0.01% 3884
2013
Q2
$241K Buy
+18,386
New +$248K ﹤0.01% 4116

Other funds holding ECYT